Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $712.3550 (-9.14%) ($712.3550 - $712.3550) on Tue. Jun. 27, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 41 | Latest Price | $712.3550(-9.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.8% a day on average for past five trading days. | Weekly Trend | REGN advances 1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(43%) DIA(30%) VYM(28%) XLF(28%) | Factors Impacting REGN price | REGN will decline at least -0.835% in a week (0% probabilities). VXX(-25%) VIXM(-20%) EDOC(-19%) TBT(-3%) UUP(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | -4.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $755.67 | 5 Day Moving Average | $766.9(-7.11%) | 10 Day Moving Average | $769.86(-7.47%) | 20 Day Moving Average | $755.67(-5.73%) | To recent high | -14.2% | To recent low | 0% | Market Cap | $75.53b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |